CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,273,000 | -33.4% | 462,852 | 0.0% | 0.08% | -27.9% |
| Q2 2019 | $3,411,000 | -9.1% | 462,852 | 0.0% | 0.10% | -19.4% |
| Q1 2019 | $3,754,000 | +93.4% | 462,852 | +88.2% | 0.13% | +50.0% |
| Q4 2018 | $1,941,000 | -26.8% | 246,000 | 0.0% | 0.09% | -11.3% |
| Q3 2018 | $2,652,000 | -7.6% | 246,000 | 0.0% | 0.10% | -18.5% |
| Q2 2018 | $2,871,000 | – | 246,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |